blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0390114

EP0390114 - Suppression of parathyroid hormone synthesis and secretion with vitamin D3 derivatives [Right-click to bookmark this link]
Former [1990/40]Suppression of parathyroid hormone synthesis and secretion with vitamen D3 derivatives
[1994/38]
StatusNo opposition filed within time limit
Status updated on  22.07.1995
Database last updated on 05.07.2024
Most recent event   Tooltip22.07.1995No opposition filed within time limitpublished on 13.09.1995 [1995/37]
Applicant(s)For all designated states
Chugai Seiyaku Kabushiki Kaisha
5-1, 5-chome, Ukima Kita-ku
Tokyo / JP
[N/P]
Former [1990/40]For all designated states
Chugai Seiyaku Kabushiki Kaisha
5-1, 5-chome, Ukima Kita-ku
Tokyo / JP
Inventor(s)01 / Slatopolsky, Eduardo, Washington University School
of Medicine, 4949 Barnes Hospital Plaza
St. Louis, Missouri 63110 / US
[1990/40]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [1990/40]VOSSIUS & PARTNER
Postfach 86 07 67
D-81634 München / DE
Application number, filing date90105922.028.03.1990
[1990/40]
Priority number, dateUS1989032960628.03.1989         Original published format: US 329606
[1990/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0390114
Date:03.10.1990
Language:EN
[1990/40]
Type: A3 Search report 
No.:EP0390114
Date:30.10.1991
Language:EN
[1991/44]
Type: B1 Patent specification 
No.:EP0390114
Date:21.09.1994
Language:EN
[1994/38]
Search report(s)(Supplementary) European search report - dispatched on:EP11.09.1991
ClassificationIPC:A61K31/59
[1990/40]
CPC:
A61K31/59 (EP,KR,US); A61P5/12 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   IT,   LI,   SE [1990/40]
TitleGerman:Unterdrückung der Synthese und der Sekretion des Nebenschilddrüsenhormons mit Vitamin D3-Derivaten[1994/38]
English:Suppression of parathyroid hormone synthesis and secretion with vitamin D3 derivatives[1994/38]
French:Suppression de la synthèse et de la sécrétion de l'hormone parathyroidienne avec dérivés de la vitamine D3[1994/38]
Former [1990/40]Ünterdrückung der Synthese und der Sekretion des Nebenschilddrüsenhormons mit Vitamin D3-Derivaten
Former [1990/40]Suppression of parathyroid hormone synthesis and secretion with vitamen D3 derivatives
Former [1990/40]Suppression de la synthèse et de la sécrétion de l'hormone parathyroidienne avec dérivés de la vitamine D3
Examination procedure28.12.1990Examination requested  [1991/10]
09.12.1993Despatch of communication of intention to grant (Approval: Yes)
29.03.1994Communication of intention to grant the patent
28.06.1994Fee for grant paid
28.06.1994Fee for publishing/printing paid
Opposition(s)22.06.1995No opposition filed within time limit [1995/37]
Fees paidRenewal fee
30.03.1992Renewal fee patent year 03
30.03.1993Renewal fee patent year 04
31.03.1994Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]JP228114  ;
 [A]JP61267550  ;
 [A]EP0301167  (TEVA PHARMA [IL])
 [A]  - PATENT ABSTRACTS OF JAPAN, vol. 14, no. 180 (C-708)[4123], 11th April 1990; & JP-A-2 28 114 (CHUGAI PHARMACEUT. CO., LTD) 30-01-1990, & JP228114 A 00000000
 [A]  - PATENT ABSTRACTS OF JAPAN, vol. 11, no. 132 (C-417)[2579], 24th April 1987; & JP-A-61 267 550 (CHUGAI PHARMACEUT. CO., LTD) 27-11-1986, & JP61267550 A 00000000
 [A]  - VITAMIN D. MOLECULAR, CELLULAR AND CLINICAL ENDOCRIONOLOGY, PROCEEDINGS OF THE 7TH WORKSHOP ON VITAMIN D, Rancho Mirage, CA, April 1988, ed. A.W. Norman et al., Department of Biochemistry, University of California, pages 739-747, Walter de Gruyter & Co., Berlin, DE; J.A. KANIS et al.: "Prospects for the modelling of vitamin D activity in man"
 [XP]  - CLINICAL RESEARCH, vol. 37, no. 2, 1989, page 569A, PROCEEDINGS OF THE NAT. MEET. AM. SOC. CLIN. INVEST., 28th April - 1st May 1989; A. BROWN et al.: "A novel non-calcemic vitamin D analog 22-oxacalcitriol (OCT) for the treatment of hyperparathyroidism"
ExaminationJP61267550
    - & JP-A-61 267 550 (CHUGAI PHARMACEUT. CO., LTD) 27-11-1986, & JP61267550 A 00000000
by applicantEP0184112
    - "Mineral Nutrients", ROLLINSON ET AL., Kirk-Othmer Encyclopedia of Chemical Technology, JOHN WILEY & SONS, (1981), vol. 15, page 585
    - REISS ET AL., TRANS. ASSOC. AM. PHYSICIANS, (1968), vol. 81, pages 104 - 115
    - ARNAUD, KIDNEY INT., (1973), vol. 4, pages 89 - 95
    - SLATOPOLSKY ET AL., J. CLIN. INVEST., (1984), vol. 74, pages 2136 - 3143
    - BROWN ET AL., J. CLIN. ENDOCRINOL. METAB., (1982), vol. 54, pages 172 - 179
    - CHERTOW ET AL., J. CLIN. INVEST., (1983), vol. 72, pages 1851 - 1855
    - CANTLEY ET AL., ENDOCRINOLOGY, (1985), vol. 117, pages 2114 - 2119
    - CHAN ET AL., CALCIF. TISSUE INT., (1986), vol. 38, pages 27 - 32
    - SILVER ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 4270 - 4273
    - RUSSELL ET AL., ENDOCRINOLOGY, (1986), vol. L19, pages 2864 - 2866
    - SILVER ET AL., J. CLIN. INVEST., (1986), vol. 78, pages 1296 - 1301
    - OSTREM ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 2610 - 2614
    - BINDERUP ET AL., BIOCHEMICAL PHARMACOLOGY, (1988), vol. 37, pages 889 - 895
    - ABE ET AL., FEBS LETT., (1987), vol. 226, pages 58 - 62
    - MURAYAMA ET AL., CHEM. PHARM. BULL., (1987), vol. 34, pages 4410 - 4413
    - BROWN ET AL., ENDOCRINOLOGY, (1972), vol. 99, pages 1582 - 1588
    - MORRISSEY ET AL., ENDOCRINOLOGY, (1978), vol. 103, pages 2081 - 2090
    - HRUSKA ET AL., J. CLIN.INVEST., (1975), vol. 56, pages 39 - 48
    - BRADFORD, ANAL. BIOCHEM., (1976), vol. 72, pages 248 - 254
 US19880211096
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.